Table of Content

Table of Contents
Table of Contents
1 Industry Overview
1.1 Myotonic Dystrophy Drug Industry
Figure Myotonic Dystrophy Drug Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Myotonic Dystrophy Drug
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Myotonic Dystrophy Drug
1.2.2 Downstream
Table Application Segment of Myotonic Dystrophy Drug
Table Global Myotonic Dystrophy Drug Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Myotonic Dystrophy Drug Market by Type
3.1 By Type
3.1.1 ISIS-DMPKRx 
Table Major Company List of ISIS-DMPKRx 
3.1.2 PRO-135 
Table Major Company List of PRO-135 
3.1.3 SRT-152 
Table Major Company List of SRT-152 
3.1.4 VAL-0411 
Table Major Company List of VAL-0411 
3.1.5 Others
Table Major Company List of Others
3.2 Market Size
Table Global Myotonic Dystrophy Drug Market 2016-2020, by Type, in USD Million
Figure Global Myotonic Dystrophy Drug Market Growth 2016-2020, by Type, in USD Million
Table Global Myotonic Dystrophy Drug Market 2016-2020, by Type, in Volume
Figure Global Myotonic Dystrophy Drug Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Myotonic Dystrophy Drug Market Forecast 2021-2026, by Type, in USD Million
Table Global Myotonic Dystrophy Drug Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 BioMarin Pharmaceutical Inc.  (Company Profile, Sales Data etc.)
4.1.1 BioMarin Pharmaceutical Inc.  Profile
Table BioMarin Pharmaceutical Inc.  Overview List
4.1.2 BioMarin Pharmaceutical Inc.  Products & Services
4.1.3 BioMarin Pharmaceutical Inc.  Business Operation Conditions
Table Business Operation of BioMarin Pharmaceutical Inc.  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 F. Hoffmann-La Roche Ltd.  (Company Profile, Sales Data etc.)
4.2.1 F. Hoffmann-La Roche Ltd.  Profile
Table F. Hoffmann-La Roche Ltd.  Overview List
4.2.2 F. Hoffmann-La Roche Ltd.  Products & Services
4.2.3 F. Hoffmann-La Roche Ltd.  Business Operation Conditions
Table Business Operation of F. Hoffmann-La Roche Ltd.  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Genzyme Corporation  (Company Profile, Sales Data etc.)
4.3.1 Genzyme Corporation  Profile
Table Genzyme Corporation  Overview List
4.3.2 Genzyme Corporation  Products & Services
4.3.3 Genzyme Corporation  Business Operation Conditions
Table Business Operation of Genzyme Corporation  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Isis Pharmaceuticals, Inc.  (Company Profile, Sales Data etc.)
4.4.1 Isis Pharmaceuticals, Inc.  Profile
Table Isis Pharmaceuticals, Inc.  Overview List
4.4.2 Isis Pharmaceuticals, Inc.  Products & Services
4.4.3 Isis Pharmaceuticals, Inc.  Business Operation Conditions
Table Business Operation of Isis Pharmaceuticals, Inc.  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Marina Biotech, Inc.  (Company Profile, Sales Data etc.)
4.5.1 Marina Biotech, Inc.  Profile
Table Marina Biotech, Inc.  Overview List
4.5.2 Marina Biotech, Inc.  Products & Services
4.5.3 Marina Biotech, Inc.  Business Operation Conditions
Table Business Operation of Marina Biotech, Inc.  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Valentia Biopharma S.L (Company Profile, Sales Data etc.)
4.6.1 Valentia Biopharma S.L Profile
Table Valentia Biopharma S.L Overview List
4.6.2 Valentia Biopharma S.L Products & Services
4.6.3 Valentia Biopharma S.L Business Operation Conditions
Table Business Operation of Valentia Biopharma S.L (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Myotonic Dystrophy Drug Sales Revenue 2016-2020, by Company, in USD Million
Table Global Myotonic Dystrophy Drug Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Myotonic Dystrophy Drug Sales Revenue Share in 2020, by Company, in USD Million
Table Global Myotonic Dystrophy Drug Sales Volume 2016-2020, by Company, in Volume
Table Global Myotonic Dystrophy Drug Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Myotonic Dystrophy Drug Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Myotonic Dystrophy Drug Market Concentration, in 2020
Figure Europe Myotonic Dystrophy Drug Market Market Concentration, in 2020
Figure Asia-Pacific Myotonic Dystrophy Drug MMarket Concentration, in 2020
Figure South America Myotonic Dystrophy Drug Market Concentration, in 2020
Figure Middle East & Africa Myotonic Dystrophy Drug Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Hospital 
Figure Myotonic Dystrophy Drug Demand in Hospital , 2016-2020, in USD Million
Figure Myotonic Dystrophy Drug Demand in Hospital , 2016-2020, in Volume
6.1.2 Demand in Clinic 
Figure Myotonic Dystrophy Drug Demand in Clinic , 2016-2020, in USD Million
Figure Myotonic Dystrophy Drug Demand in Clinic , 2016-2020, in Volume
6.1.3 Demand in Home Use 
Figure Myotonic Dystrophy Drug Demand in Home Use , 2016-2020, in USD Million
Figure Myotonic Dystrophy Drug Demand in Home Use , 2016-2020, in Volume
6.1.4 Demand in Others
Figure Myotonic Dystrophy Drug Demand in Others, 2016-2020, in USD Million
Figure Myotonic Dystrophy Drug Demand in Others, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Myotonic Dystrophy Drug Demand Forecast 2021-2026, by Application, in USD Million
Figure Myotonic Dystrophy Drug Market Growth 2021-2026, by Application, in USD Million
Figure Myotonic Dystrophy Drug Market Share in 2026, by Application, in USD Million
Table Myotonic Dystrophy Drug Demand Forecast 2021-2026, by Application, in Volume
Table Myotonic Dystrophy Drug Market Growth 2021-2026, by Application, in Volume
Table Myotonic Dystrophy Drug Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Myotonic Dystrophy Drug Production 2016-2020, by Region, in USD Million
Table Myotonic Dystrophy Drug Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Myotonic Dystrophy Drug Market 2016-2020, by Region, in USD Million
Table Global Myotonic Dystrophy Drug Market Share 2016-2020, by Region, in USD Million
Table Global Myotonic Dystrophy Drug Market 2016-2020, by Region, in Volume
Table Global Myotonic Dystrophy Drug Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Myotonic Dystrophy Drug Market Size and Growth 2016-2020, in USD Million
Figure North America Myotonic Dystrophy Drug Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Myotonic Dystrophy Drug Market Size 2016-2020, by Country, in USD Million
Table North America Myotonic Dystrophy Drug Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Myotonic Dystrophy Drug Market Size and Growth 2016-2020, in USD Million
Figure Europe Myotonic Dystrophy Drug Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Myotonic Dystrophy Drug Market Size 2016-2020, by Country, in USD Million
Table Europe Myotonic Dystrophy Drug Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Myotonic Dystrophy Drug Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Myotonic Dystrophy Drug Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Myotonic Dystrophy Drug Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Myotonic Dystrophy Drug Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Myotonic Dystrophy Drug Market Size and Growth 2016-2020, in USD Million
Figure South America Myotonic Dystrophy Drug Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Myotonic Dystrophy Drug Market Size 2016-2020, by Country, in USD Million
Table South America Myotonic Dystrophy Drug Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Myotonic Dystrophy Drug Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Myotonic Dystrophy Drug Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Myotonic Dystrophy Drug Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Myotonic Dystrophy Drug Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Myotonic Dystrophy Drug Market Forecast 2021-2026, by Region, in USD Million
Table Myotonic Dystrophy Drug Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion

List of Figure

List of Table
List of Table
1. Table Upstream Segment of Myotonic Dystrophy Drug
2. Table Application Segment of Myotonic Dystrophy Drug
3. Table Global Myotonic Dystrophy Drug Market 2016-2026, by Application, in USD Million
4. Table Major Company List of PRO-135 
5. Table Major Company List of SRT-152 
6. Table Major Company List of VAL-0411 
7. Table Major Company List of Others
8. Table Global Myotonic Dystrophy Drug Market 2016-2020, by Type, in USD Million
9. Table Global Myotonic Dystrophy Drug Market 2016-2020, by Type, in Volume
10. Table Global Myotonic Dystrophy Drug Market Forecast 2021-2026, by Type, in USD Million
11. Table Global Myotonic Dystrophy Drug Market Forecast 2021-2026, by Type, in Volume
12. Table BioMarin Pharmaceutical Inc.  Overview List
13. Table Business Operation of BioMarin Pharmaceutical Inc.  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
14. Table F. Hoffmann-La Roche Ltd.  Overview List
15. Table Business Operation of F. Hoffmann-La Roche Ltd.  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
16. Table Genzyme Corporation  Overview List
17. Table Business Operation of Genzyme Corporation  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
18. Table Isis Pharmaceuticals, Inc.  Overview List
19. Table Business Operation of Isis Pharmaceuticals, Inc.  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
20. Table Marina Biotech, Inc.  Overview List
21. Table Business Operation of Marina Biotech, Inc.  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
22. Table Valentia Biopharma S.L Overview List
23. Table Business Operation of Valentia Biopharma S.L (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
24. Table Global Myotonic Dystrophy Drug Sales Revenue 2016-2020, by Company, in USD Million
25. Table Global Myotonic Dystrophy Drug Sales Revenue Share 2016-2020, by Company, in USD Million
26. Table Global Myotonic Dystrophy Drug Sales Volume 2016-2020, by Company, in Volume
27. Table Global Myotonic Dystrophy Drug Sales Volume Share 2016-2020, by Company, in Volume
28. Table Regional Demand Comparison List
29. Table Major Application in Different Regions
30. Table Myotonic Dystrophy Drug Demand Forecast 2021-2026, by Application, in USD Million
31. Table Myotonic Dystrophy Drug Demand Forecast 2021-2026, by Application, in Volume
32. Table Myotonic Dystrophy Drug Market Growth 2021-2026, by Application, in Volume
33. Table Myotonic Dystrophy Drug Market Share in 2026, by Application, in Volume
34. Table Myotonic Dystrophy Drug Production 2016-2020, by Region, in USD Million
35. Table Myotonic Dystrophy Drug Production 2016-2020, by Region, in Volume
36. Table Global Myotonic Dystrophy Drug Market 2016-2020, by Region, in USD Million
37. Table Global Myotonic Dystrophy Drug Market Share 2016-2020, by Region, in USD Million
38. Table Global Myotonic Dystrophy Drug Market 2016-2020, by Region, in Volume
39. Table Global Myotonic Dystrophy Drug Market Share 2016-2020, by Region, in Volume
40. Table North America Myotonic Dystrophy Drug Market Size 2016-2020, by Country, in USD Million
41. Table North America Myotonic Dystrophy Drug Market Size 2016-2020, by Country, in Volume
42. Table Europe Myotonic Dystrophy Drug Market Size 2016-2020, by Country, in USD Million
43. Table Europe Myotonic Dystrophy Drug Market Size 2016-2020, by Country, in Volume
44. Table Asia-Pacific Myotonic Dystrophy Drug Market Size 2016-2020, by Country, in USD Million
45. Table Asia-Pacific Myotonic Dystrophy Drug Market Size 2016-2020, by Country, in Volume
46. Table South America Myotonic Dystrophy Drug Market Size 2016-2020, by Country, in USD Million
47. Table South America Myotonic Dystrophy Drug Market Size 2016-2020, by Country, in Volume
48. Table Middle East & Africa Myotonic Dystrophy Drug Market Size 2016-2020, by Country, in USD Million
49. Table Middle East & Africa Myotonic Dystrophy Drug Market Size 2016-2020, by Country, in Volume
50. Table Myotonic Dystrophy Drug Market Forecast 2021-2026, by Region, in USD Million
51. Table Myotonic Dystrophy Drug Market Forecast 2021-2026, by Region, in Volume
52. Table Price Factors List